None
Quote | Sesen Bio Inc. (NASDAQ:SESN)
Last: | $0.6288 |
---|---|
Change Percent: | 2.2% |
Open: | $0.5732 |
Close: | $0.6288 |
High: | $0.6288 |
Low: | $0.57 |
Volume: | 1,792,571 |
Last Trade Date Time: | 03/07/2023 03:00:00 am |
News | Sesen Bio Inc. (NASDAQ:SESN)
Sesen Bio ( NASDAQ: SESN ) stockholders on Thursday approved effecting a 1-for-20 reverse stock split of the company's issued and outstanding shares. The information was disclosed in a regulatory filing . The reverse stock split will be effective as of March 7. The reverse...
Clinical-stage biotech Sesen Bio ( NASDAQ: SESN ) announced Thursday that its shareholders greenlighted the company’s pending merger with Carisma Therapeutics at a special meeting of stockholders held today. Based on early voting results, more than 88% of votes were in favor of...
Message Board Posts | Sesen Bio Inc. (NASDAQ:SESN)
Subject | By | Source | When |
---|---|---|---|
Anybody get there special dividend? | govprs | investorshub | 03/24/2023 7:42:56 PM |
No CARM board? | joe_techi | investorshub | 03/21/2023 4:39:29 PM |
I voted no. Considering the special dividend and | joe_techi | investorshub | 03/11/2023 10:02:38 PM |
Yep, they usually are. Listing requirements demand them. | SmellMyFinger | investorshub | 03/10/2023 5:44:11 PM |
We have been totally hosed | Oxonius | investorshub | 03/10/2023 2:51:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...